Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$830M |
| 2 |
UnitedHealth
UNH
|
+$769M |
| 3 |
Arthur J. Gallagher & Co
AJG
|
+$691M |
| 4 |
Amazon
AMZN
|
+$654M |
| 5 |
Bank of America
BAC
|
+$634M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 2 |
NVIDIA
NVDA
|
+$550M |
| 3 |
Spotify
SPOT
|
+$473M |
| 4 |
Citigroup
C
|
+$460M |
| 5 |
Boston Scientific
BSX
|
+$428M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 3.13% |
| 2 | Technology | 2.97% |
| 3 | Financials | 2.19% |
| 4 | Consumer Discretionary | 2.09% |
| 5 | Industrials | 1.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1876
PUT
Shift4
FOUR
$3.58B
| $25.7M | ﹤0.01% |
248,100
+43,400
| +21% | +$4.31M |
|
1877
Stellantis
STLA
$20.2B
| $25.7M | ﹤0.01% |
1,971,510
+1,031,476
| +110% | +$13.7M |
|
|
SNCY
1878
DELISTED
Sun Country Airlines
SNCY
| $25.7M | ﹤0.01% |
1,763,954
+264,956
| +18% | +$3.59M |
|
1879
CALL
Alpha Metallurgical Resources
AMR
$2.11B
| $25.7M | ﹤0.01% |
128,300
-70,800
| -36% | -$15.9M |
|
1880
CALL
NetApp
NTAP
$40.6B
| $25.6M | ﹤0.01% |
220,900
-248,700
| -53% | -$30.4M |
|
1881
PUT
Scorpio Tankers
STNG
$3.98B
| $25.6M | ﹤0.01% |
514,900
+151,300
| +42% | +$8.63M |
|
1882
PUT
AeroVironment
AVAV
$9.76B
| $25.6M | ﹤0.01% |
166,200
+64,900
| +64% | +$12.7M |
|
1883
BioMarin Pharmaceuticals
BMRN
$13B
| $25.5M | ﹤0.01% |
387,613
-816,784
| -68% | -$54.7M |
|
1884
CALL
Core Scientific
CORZ
$6.48B
| $25.4M | ﹤0.01% |
1,810,310
+478,500
| +36% | +$7.07M |
|
1885
PUT
Direxion Daily Technology Bull 3x ETF
TECL
$6.39B
| $25.4M | ﹤0.01% |
280,500
+86,400
| +45% | +$8.06M |
|
1886
PUT
Novartis
NVS
$287B
| $25.4M | ﹤0.01% |
260,800
+152,900
| +142% | +$16.3M |
|
1887
CALL
Viking Therapeutics
VKTX
$3.87B
| $25.4M | ﹤0.01% |
630,500
-435,000
| -41% | -$24.8M |
|
1888
PUT
Canadian Pacific Kansas City
CP
$82.2B
| $25.3M | ﹤0.01% |
349,500
+244,700
| +233% | +$18.9M |
|
1889
PUT
Vornado Realty Trust
VNO
$7.28B
| $25.3M | ﹤0.01% |
601,500
+37,300
| +7% | +$1.58M |
|
1890
PUT
Everest Group
EG
$14.2B
| $25.3M | ﹤0.01% |
69,700
+24,600
| +55% | +$9.21M |
|
1891
CALL
Carrier Global
CARR
$51.8B
| $25.2M | ﹤0.01% |
369,900
-141,600
| -28% | -$10.7M |
|
1892
UiPath
PATH
$8.3B
| $25.2M | ﹤0.01% |
1,986,159
+1,508,113
| +315% | +$19.9M |
|
1893
Unum
UNM
$14.8B
| $25.2M | ﹤0.01% |
345,025
+186,196
| +117% | +$12.8M |
|
1894
PUT
BJs Wholesale Club
BJ
$11.9B
| $25.2M | ﹤0.01% |
282,000
+99,700
| +55% | +$9.01M |
|
1895
Life Time Group Holdings
LTH
$10.1B
| $25.2M | ﹤0.01% |
+1,137,559
| New | +$27.2M |
|
1896
CALL
Sweetgreen
SG
$748M
| $25.1M | ﹤0.01% |
784,300
-329,400
| -30% | -$12.3M |
|
1897
Spyre Therapeutics
SYRE
$9.14B
| $25.1M | ﹤0.01% |
1,079,307
+371,721
| +53% | +$10.9M |
|
1898
PUT
Quanta Services
PWR
$103B
| $25.1M | ﹤0.01% |
79,400
-32,700
| -29% | -$10.5M |
|
1899
NewAmsterdam Pharma
NAMS
$3.23B
| $25.1M | ﹤0.01% |
975,831
+453,366
| +87% | +$9.63M |
|
1900
Erie Indemnity
ERIE
$13.4B
| $25M | ﹤0.01% |
60,682
+33,754
| +125% | +$15.1M |
|
Similar funds
Ken Griffin's Q4 2024 Portfolio in Review
As of Q4 2024, Ken Griffin held 15,826 positions worth $578B, up 11% from $518B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Ken Griffin deployed $35.2B of net new capital in Q4 2024, opening 1,745 new positions and adding to 6,428 existing holdings. Its largest new stake was Zoetis: 1,090,499 shares worth $178M.
By sector, the portfolio is most concentrated in Healthcare at 3.1% of assets, up from 2.9% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.23B trimmed.
- Ken Griffin's largest Q4 2024 buy was Zoetis: 1,090,499 shares worth $178M.
- Ken Griffin added most to Boeing in Q4 2024, an estimated $830M increase.
- Ken Griffin's biggest Q4 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.23B.
- Ken Griffin fully exited Spotify in Q4 2024, selling an estimated $473M.
- Ken Griffin's ten largest holdings make up 31% of its $578B portfolio in Q4 2024.
- Ken Griffin opened 1,745 new positions and closed 1,423 in Q4 2024.
- Ken Griffin's portfolio value rose 11% quarter-over-quarter to $578B.
Based on Citadel Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.